PEGylated lipidic systems with prolonged circulation longevity for drug delivery in cancer therapeutics

Journal of Drug Delivery Science and Technology

Volumn 21, Issue 1, 2011, Pages 27-34

  Maitani, Y ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Cancer; Diagnosis; Drug delivery; Emulsion; Gene delivery; Lipidic particle; Liposome; PEG lipid; Prolonged circulation; Targeting

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; CHOLESTEROL; CYTARABINE; DAUNORUBICIN; DIPALMITOYLPHOSPHATIDYLGLYCEROL; DOXORUBICIN; GANCICLOVIR; LIPID; MACROGOL; MACROGOL 10000; MACROGOL 2000; NANOPARTICLE; PHOSPHATIDYLCHOLINE; POLYSORBATE 80;

CANCER CELL; CANCER THERAPY; CIRCULATION; DRUG DELIVERY SYSTEM; EMULSION; GENE DELIVERY SYSTEM; LIPOSOMAL DELIVERY; LONGEVITY; NANOEMULSION; NONHUMAN; PHYSICAL CHEMISTRY; REVIEW;

EID: 79952204419     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(11)50003-6     Document Type: Review

References (82)

1. Matsumura Y., Maeda H. - A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. - Cancer Res., 46, 6387-6392, 1986. (Pubitemid 17221789)
2. Bangham A.D., Standish M.M., Watkins J.C. - Diffusion of univalent ions across the lamellae of swollen phospholipids. - J. Mol. Biol., 13 (1), 238-252, 1965.
3. Klibanov A.L., Maruyama K., Torchilin V.P., Huang L. - Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. - FEBS Lett., 268 (1), 235-237, 1990. (Pubitemid 20233874)
4. Blume G., Cevc G. - One of the first publications demonstrating the prolonged circulation time of PEG-modified liposomes - Biochim. Biophys. Acta, 1029 (1), 91-97, 1990.
5. Woodle M.C., Lasic D.D. - Sterically stabilized liposomes. - Biochim. Biophys. Acta, 113, 171-199, 1992.
6. Torchilin V.P., Omelyanenko V.G., Papisov M.I., Bogdanov A.A. Jr, Trubetskoy V.S., Herron J.N., Gentry C.A. - Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. - Biochim. Biophys. Acta, 1195 (1), 11-20, 1994.
7. Chonn A., Semple S.C., Cullis P.R. - Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. - J. Biol. Chem., 267 (26), 18759-18765, 1992.
8. Johnstone S.A., Masin D., Mayer L., Bally M.B. - Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages. - Biochim. Biophys. Acta, 1513 (1), 25-37, 2001.
9. Watanabe M., Kawano K., Toma K., Hattori Y., Maitani Y. - In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin - J. Control. Rel., 127 (3), 231-238, 2008.
10. Johnston M.J., Semple S.C., Klimuk S.K., Edwards K., Eisenhardt M.L., Leng E.C., Karlsson G., Yanko D., Cullis P.R. - Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. - Biochim. Biophys. Acta, 1758 (1), 55-64, 2006.
11. Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Redemann C., Martin F.J., Papahadjopoulos D. - Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. - Biochim. Biophys. Acta, 113, 193-200, 1992.
12. Allen T.M., Hansen C.B., Lopes de Menezes D.E. - Pharmacokinetics of long circulating liposomes. - Adv. Drug Del. Rev., 16, 267-284, 1995.
13. Parr M.J., Masin D., Cullis P.R., Bally M.B. - Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol). - J. Pharmacol. Exp. Ther., 280 (3), 1319-1327, 1997.
14. Hong R.L., Huang C.J., Tseng Y.L., Pang V.F., Chen S.T., Liu J.J., Chang F.H. - Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial? - Clin. Cancer Res., 5 (11), 3645-3652, 1999.
15. Cui J., Li C., Guo W., Li Y., Wang C., Zhang L., Zhang L., Hao Y., Wang Y. - Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy? - J. Control. Rel., 118 (2), 204-215, 2007.
16. Allen T.M., Hansen C.B., Guo L.S. - Subcutaneous administration of liposomes: a comparison with the intravenous and intraperitoneal routes of injection - Biochim. Biophys. Acta, 1150 (1), 9-16, 1993.
17. Phillips W.T., Klipper R., Goins B. - Novel method of greatly enhanced delivery of liposomes to lymph nodes. - J. Pharmacol. Exp. Ther., 295 (1), 309-313, 2000.
18. Kim C.K., Han J.H. - Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats. - J. Microencapsul., 12 (4), 437-446, 1995.
19. Kajiwara E., Kawano K., Hattori Y., Fukushima M., Hayashi K., Maitani Y. - Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy. - J. Control. Rel., 120 (1-2), 104-110, 2007.
20. De Gennes P.G., Taupin C. - Microemulsion and the flexibility of oil/water interfaces. - J. Phys. Chem., 86, 2294-2304, 1982.
21. Liu F., Liu D. - Long-circulating emulsions (oil-in-water) as carriers for lipophilic drugs. - Pharm Res., 12(7), 1060-1064, 1995.
22. Khopade A.J., Shelly C., Pandit N.K., Banakar U.V. - Liposphere based lipoprotein-mimetic delivery system for 6-mercaptopurine. - J. Biomater. Appl., 14 (4), 389-398, 2000.
23. Shiokawa T., Hattori Y., Kawano K., Ohguchi Y., Kawakami H., Toma K., Maitani Y. - Effect of the polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin a on targeting ability and antitumor effect in vitro and in vivo - Clinical Cancer Res., 11 (5), 2018-2025, 2005.
24. Ohguchi Y., Kawano K., Hattori Y., Maitani Y. - Selective delivery of folate-PEG-linked nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: effect of chain length and amount of folate-PEG linker. - J. Drug Target., 16 (9), 660-667, 2008.
25. Reddy P.R., Venkateswarlu V. - Pharmacokinetics and tissue distribution of etoposide delivered in long circulating parenteral emulsion. - J. Drug Target., 13 (10), 543-553, 2005.
26. Ganta S., Sharma P., Paxton J.W., Baguley B.C., Garg S. - Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion. - J. Drug Target., 18, 125-133, 2009.
27. Dierling A.M., Sloat B.R., Cui Z. - Gadolinium incorporated reconstituted chylomicron emulsion for potential application in tumor neutron capture therapy. - Eur. J. Pharm. Biopharm., 62 (3), 275-281, 2006.
28. Ko Y.T., Bhattacharya R., Bickel U. - Liposome encapsulated polyethylenimine/ODN polyplexes for brain targeting. - J. Control. Rel., 133 (3), 230-237, 2009.
29. Mikhaylova M., Stasinopoulos I., Kato Y., Artemov D., Bhujwalla Z.M. - Imaging of cationic multifunctional liposome-mediated delivery of COX-2 siRNA. - Cancer GeneTher., 16 (3), 217-226, 2009.
30. Morille M., Montier T., Legras P., Carmoy N., Brodin P., Pitard B., Benoît J.P., Passirani C. - Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. - Biomaterials, 31 (2), 321-329, 2010.
31. Li S.D., Huang L. - Surface-modified LPD nanoparticles for tumor targeting. - Ann. NY Acad. Sci., 1082, 1-8, 2006.
32. Sonoke S., Ueda T., Fujiwara K., Sato Y., Takagaki K., Hirabayashi K., Ohgi T., Yano J. - Tumor regression in mice by delivery of Bcl-2 small interfering RNA with pegylated cationic liposomes. - Cancer Res., 68 (21), 8843-8851, 2008.
33. Aleku M., Schulz P., Keil O., Santel A., Schaeper U., Dieckhoff B., Janke O., Endruschat J., Durieux B., Röder N., Löffler K., Lange C., Fechtner M., Möpert K., Fisch G., Dames S., Arnold W.., Jochims K., Giese K., Wiedenmann B., Scholz A., Kaufmann J. - Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression. - Cancer Res., 68 (23), 9788-9798, 2008.
34. Alberts D.S., Garcia D.J. - Safety aspects of pegylated liposomal doxorubicin in patients with cancer. - Drugs, 54, 30-35, 1997. (Pubitemid 27487793)
35. Brouwers A.H., De Jong D.J., Dams E.T.M. et al. - Tc99mPEG-liposomes for the evaluation of colitis in Crohn's disease - J. Drug Target., 8 (4), 225-233, 2000.
36. Moghimi S.M., Hamad I., AndresenT.L., Jørgensen K., Szebeni J. - Methylation of the phosphate oxygen moiety of phospholipid-methoxy(polyethylene glycol) conjugate prevents PEGylated liposome-mediated complement activation and anaphylatoxin production. - FASEB J., 20 (14), 2591-2593, 2006.
37. Laverman P., Brouwers A.H., Dams E.T., Oyen W.J., Storm G., van Rooijen N., Corstens F.H., Boerman O.C. - Preclinical and clinical evidence for disappearance of long-circulating characteristics of polyethylene glycol liposomes at low lipid dose, - J. Pharmacol. Exp. Ther., 293 (3), 996-1001, 2000. (Pubitemid 30417869)
38. Lu W., Wan J., She Z.J., Jiang X.G. - Brain delivery property and accelerated blood clearance of cationic albumin conjugated pegylated nanoparticle - J. Control. Rel., 118(1), 38-53, 2007.
39. Ma H., Shiraishi K., Minowa T., Kawano K., Yokoyama M., Hattori Y., Maitani Y. - Accelerated blood clearance was not induced for a gadolinium-containing PEG-poly(L.-lysine)-based polymeric micelle in mice.- Pharm Res., 27 (2), 296-302, 2010.
40. Judge A., McClintock K., Phelps J.R., Maclachlan I. - Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. - Mol. Ther., 13 (2), 328-337, 2006.
41. Semple S.C., Harasym T.O., Clow K.A., Ansell S.M., Klimuk S.K., Hope M.J. - Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid. - J. Pharmacol. Exp. Ther., 312 (3), 1020-1026, 2005.
42. Romberg B., Hennink W.E., Storm G. - Sheddable coatings for long-circulating nanoparticles. - Nanomed., 2 (2), 169-181, 2007.
43. Heyes J., Hall K., Tailor V., Lenz R., MacLachlan I. - Synthesis and characterization of novel poly(ethylene glycol)-lipid conjugates suitable for use in drug delivery. - J. Control. Rel., 112 (2), 280-290, 2006.
44. Simoes S., Moreira J.N., Fonseca C., Duzgunes N., deLima M.C. - On the formulation of pH-sensitive liposomes with long circulation times. - Adv. Drug Deliv. Rev., 56, 947-965, 2004.
45. Hong M.S., Lim S.J., Oh Y.K., Kim C.K. - pH-sensitive, serum-stable and long-circulating liposomes as a new drug delivery system. - J. Pharm Pharmacol., 54 (1), 51-58, 2002.
46. Ishida T., Kirchmeier M.J., Moase E.H., Zalipsky S., Allen T.M. - Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. - Biochim. Biophys. Acta, 1515 (2), 144-158, 2001.
47. Hatakeyama H., Akita H., Kogure K., Oishi M., Nagasaki Y., Kihira Y., Ueno M., Kobayashi H., Kikuchi H., Harashima H.. - Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. - Gene Ther., 14(1), 68-77, 2007. (Pubitemid 44942867)
48. Carmona S., Jorgensen M.R., Kolli S., Crowther C., Salazar F.H., Marion P.L., Fujino M., Natori Y., Thanou M., Arbuthnot P., Miller A.D. - Controlling HBV replication in vivo by intravenous administration of triggered PEGylated siRNA-nanoparticles. - Mol. Pharm., 6 (3), 706-717, 2009.
49. Lee R.J., Low P.S. - Delivery of liposomes into cultured KB cells via folate receptor-mediated endocytosis. - J. Biol. Chem., 269 (5), 3198-3204, 1994.
50. Allen T.M., Brandeis E., Hansen C.B., Kao G.Y., Zalipsky S. - A. new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancercells. - Biochim. Biophys. Acta, 1237 (2), 99-108, 1995.
51. Gabizon A., Horowitz A.T., Goren D., Tzemach D., Shmeeda H., Zalipsky S. - In vivo fate of folate-targeting polyethylene-glycol liposomes in tumor-bearing mice. - Clin Cancer Res., 9 (17), 6551-6559, 2003. (Pubitemid 38031844)
52. Maruyama K., Takahashi N., Tagawa T., Nagaike K., Iwatsuru M. - Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo. - FEBS Lett., 413 (1), 177-180, 1997. (Pubitemid 27348659)
53. Yu W., Pirollo K.F., Rait A., Yu B., Xiang L.M., Huang W.Q., Zhou Q., Ertem G., Chang E.H. - A. sterically stabilized immunolipoplex for systemic administration of a therapeutic gene. - Gene Ther., 11 (19), 1434-1440, 2004. (Pubitemid 39359434)
54. Kim K.S., Lee Y.K., Kim J.S., Koo K.H., Hong H.J., Park Y.S. - Targeted gene therapy of LS174 T. human colon carcinoma by anti-TAG-72 immunoliposomes. - Cancer Gene Ther., 15 (5), 331-340, 2008. (Pubitemid 351508134)
55. Rivest V., Phivilay A., Julien C., Bélanger S., Tremblay C., Emond V., Calon F. - Novel liposomal formulation for targeted gene delivery. - Pharm. Res., 24 (5), 981-990, 2007.
56. Elbayoumi T.A., Torchilin V.P. - Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody. - Clin. Cancer Res., 15 (6), 1973-1980, 2009.
57. Kirpotin D.B., Drummond D.C., Shao Y., Shalaby M.R., Hong K., Nielsen U.B., Marks J.D., Benz C.C., Park J.W. - Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. - Cancer Res., 66 (13), 6732-6740, 2006. (Pubitemid 44085631)
58. Hatakeyama H., Akita H., Ishida E., Hashimoto K., Kobayashi H., Aoki T., Yasuda J., Obata K., Kikuchi H., Ishida T., Kiwada H., Harashima H. - Tumor targeting of doxorubicin by anti-MT1- MMP antibody-modified PEG liposomes - Int. J. Pharm., 342 (1-2), 194-200, 2007. (Pubitemid 47259319)
59. Weitman S.D., Lark R.H., Coney L.R. et al. - Distribution of the folate receptor GP38 in normal and malignant cell lines and tissue. - Cancer Res., 52, 3396-3401, 1992.
60. Turek J.J., Leamon C.P., Low P.S. - Endocytosis of folate-protein conjugates: ultrastructural localization in KB cells. - J. Cell Sci., 106, 423-430, 1993.
61. Lee R.J., Low P.S. - Folate-mediated tumor cell targeting of liposome entrapped doxorubicin in vitro. - Biochim. Biophys. Acta, 1233, 134-144, 1995.
62. Reddy J.A., Abburi C., Hofland H. et al. - Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. - Gene Ther., 9, 1542-1550, 2002.
63. Antony A.C., Utley C., Van Home K.C., Kolhouse J.F. - Isolation and characterization of a folate receptor from human placenta - J. Biol. Chem., 256, 9684-9692, 1981.
64. Gabizon A., Horowitz A.T., Goren D. et al. - Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies. - Bioconjug. Chem., 10, 289-298, 1999.
65. Yamada A., Taniguchi Y., Kawano K., Honda T., Hattori Y., Maitani Y. - Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. - Clin. Cancer Res., 14 (24), 8161-8168, 2008.
66. Pan X.Q., Wang H., Lee R.J. - Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. - Pharm. Res., 20, 417-422, 2003.
67. Gabizon A., Shmeeda H., Horowitz A.T., Zalipsky S. - Tumor cell targeting of liposome-entrapped drugs with phospholipid-anchored folic acid-PEG conjugates. - Adv. Drug Deliv. Rev., 56, 1177-1192, 2004.
68. Richardson D.R., Kalinowski D.S., Lau S. et al. - Cancer cell iron metabolism and the development of potent iron chelators as antitumour agents. - Biochim. Biophys. Acta, 1790 (7), 702-717, 2009.
69. Qian Z.M., Li H.Y., Sun H.Z. et al. - Targeted drug delivery via the transferrin receptor mediated endocytosis pathway. - Pharmacol. Rev., 54 (4), 561-587, 2002.
70. Ishida O., Maruyama K., Tanahashi H., Iwatsuru M., Sasaki K., Eriguchi M., Yanagie H. - Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo. - Pharm. Res., 18 (7), 1042-1048, 2001.
71. Masunaga S., Kasaoka S., Maruyama K., Nigg D., Sakurai Y., Nagata K., Suzuki M., Kinashi Y., Maruhashi A., Ono K. - The potential of transferrin-pendant-type polyethyleneglycol liposomes encapsulating decahydrodecaborate-(10)B (GB-10) as (10)B-carriers for boron neutron capture therapy. - Int. J. Radiat. Oncol. Biol. Phys., 66 (5), 1515-1522, 2006.
72. Iinuma H., Maruyama K., Okinaga K., Sasaki K., Sekine T., Ishida O., Ogiwara N., Johkura K., Yonemura - Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. - Int. J. Cancer, 99 (1), 130-137, 2002.
73. Suzuki R., Takizawa T., Kuwata Y., Mutoh M., Ishiguro N., Utoguchi N., Shinohara A., Eriguchi M., Yanagie H., Maruyama K. - Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome. - Int. J. Pharm., 346 (1-2), 143-150, 2008.
74. Schiffelers R.M., Koning G.A., ten Hagen T.L., Fens M.H., Schraa A.J., Janssen A.P., Kok R.J., Molema G., Storm G. - Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin. - J. Control. Rel., 91 (1-2), 115-122, 2003.
75. Hood J.D., Bednarski M., Frausto R., Guccione S., Reisfeld R.A., Xiang R., Cheresh D.A. - Tumor regression by targeted gene delivery to the neovasculature. - Science, 296 (5577), 2404-2407, 2002. (Pubitemid 34734217)
76. Thompson B., Mignet N., Hofland H., Lamons D., Seguin J., Nicolazzi C., de la Figuera N., Kuen R.L., Meng X.Y., Scherman D., Bessodes M. - Neutral postgrafted colloidal particles for gene delivery. - Bioconjug Chem., 16 (3), 608-614, 2005.
77. Plassat V., Martina M.S., Barratt G., Ménager C., Lesieur S. - Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: pharmacokinetics and biodistribution. - Int. J. Pharm., 344, 118-127, 2007.
78. Kamaly N., Kalber T., Ahmad A., Oliver M.H., So P.W., Herlihy A.H., Bell J.D., Jorgensen M.R., Miller A.D. - Bimodal paramagnetic and fluorescent liposomes for cellular and tumor magnetic resonance imaging. - Bioconjug. Chem., 19 (1), 118-129, 2008.
79. Michalet X., Pinaud F.F., Bentolila L.A., Tsay J.M., Doose S., Li J.J., Sundaresan G., Wu A.M., Gambhir S.S., Weiss S. - Quantum dots for live cells, in vivo imaging, and diagnostics. - Science, 307 (5709), 538-544, 2005. (Pubitemid 40165671)
80. Dubertret B., Skourides P., Norris D.J., Noireaux V., Brivanlou A.H., Libchaber A. - In vivo imaging of quantum dots encapsulated in phospholipid micelles.- Science, 298 (5599), 1759-1762, 2002.
81. Weng K.C., Noble C.O., Papahadjopoulos-Sternberg B., Chen F.F., Drummond D.C., Kirpotin D.B., Wang D., Hom Y.K., Hann B., Park J.W. - Targeted tumor cell internalization and imaging of multifunctional quantum dot-conjugated immunoliposomes in vitro and in vivo. - Nano Lett., 8 (9), 2851-2857, 2008.
82. Al-Jamal W.T., Al-Jamal K.T., Tian B., Cakebread A., Halket J.M., Kostarelos K. - Tumor targeting of functionalized quantum dot-liposome hybrids by intravenous administration. - Mol. Pharm., 6 (2), 520-530, 2009.